{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:23Z","timestamp":1753890743241,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Adipokines are associated with cardiovascular disease; in chronic kidney disease (CKD) patients adipokines could be useful prognostic factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To explore whether leptin and adiponectin in kidney replacement therapy (KRT) children could have a role on their cardiac function, in the long-term.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective cohort study was performed with pediatric KRT patients, aged 8 to 17 years who were undergoing hemodialysis or peritoneal dialysis. At enrollment, lipid profile, adipokines (leptin, leptin receptor, free leptin, and adiponectin), anthropometric measurements and cardiological evaluation were determined. At two-year follow-up, a new cardiological evaluation was performed. <jats:italic>Statistical analysis<\/jats:italic>: Quantitative data are presented as median and interquartile range (IQR). Mann-Whitney U test and Chi-squared were used for the between-group comparison. Multivariate analyzes were performed to determine the association of adipokines levels with ventricular ejection fraction (LEVF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 56 patients, with a median age of 12.5 years. In the first cardiological evaluation, median LVEF was 70.0% (IQR 61%, 76%), 20 patients (35.7%) had some cardiovascular condition, and 10 (17.8%) altered LVEF. At 24-month follow-up, the median LVEF was 70.5% (IQR 65.1%, 77%), while the delta-LVEF values was 3% (IQR -6.5%, 7%). Delta-LVEF were correlated with baseline adipokines serum levels, and the only positive correlation found was with free leptin (r=0.303, p=0.025). In multivariate analysis, levels of free leptin (Coef. 0.12, p&amp;lt;0.036) and leptin (coef. 1.72, p=0.049), as well as baseline LVEF (Coef. -0.65, p&amp;lt;0.001) were associated with delta-LVEF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Free leptin, leptin and LVEF at the beginning of follow-up were associated with the LVEF decrease at the 24-month follow-up in KRT children.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1120445","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T05:59:28Z","timestamp":1678341568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Adipokines as predictive factor of cardiac function in pediatric patients with chronic kidney disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Miguel Angel","family":"Villasis-Keever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie Nallely","family":"Zurita-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Zepeda-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Alegria-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Serret-Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Jesus","family":"Estrada-Loza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Carolina","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alonso-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Zavala-Serret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000481366","article-title":"UK Renal registry 19th annual report: Chapter 4 demography of the UK paediatric renal replacement therapy population in 2015","volume":"137","author":"Hamilton","year":"2017","journal-title":"Nephron"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04430-4","article-title":"Long-term all-cause mortality and cardiovascular outcomes in Scottish children after initiation of renal replacement therapy: a national cohort study","volume":"35","author":"Galiyeva","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.027","article-title":"Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management","volume":"54","author":"Wilson","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.116","article-title":"Cardiovascular complications in children with chronic kidney disease","volume":"7","author":"Shoroff","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021604","article-title":"Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans","volume":"88","author":"Yannakoulia","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.2.6490","article-title":"Leptin, nutrition and reproduction: timing is everything","volume":"85","author":"Hileman","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.156596","article-title":"Leptin signaling and obesity: Cardiovascular consequences","volume":"101","author":"Yang","year":"2007","journal-title":"Circ Res"},{"key":"B10","article-title":"Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity","volume":"43","author":"Stofkova","year":"2009","journal-title":"Endocr Regul"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm154","article-title":"Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure","volume":"28","author":"Tsutamoto","year":"2007","journal-title":"Eur Hear J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040331","article-title":"Adiponectin and mortality in patients with chronic kidney disease","volume":"17","author":"Menon","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2011.11.038","article-title":"Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the heart and soul study","volume":"220","author":"Beatty","year":"2012","journal-title":"Atherosclerosis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8375828","DOI":"10.1155\/2016\/8375828","article-title":"Leptin, leptin soluble receptor, and the free leptin index following a diet and physical activity lifestyle intervention in obese males and females","volume":"2016","author":"Herrick","year":"2016","journal-title":"J Obes"},{"key":"B16","unstructured":"CDC Growth charts"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.11.031","article-title":"Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline","volume":"66","author":"Slinin","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","article-title":"KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: Classification and diagnosis: a scientific statement from the American heart association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502503S32","article-title":"Cardiovascular disease as a late complication of end-stage renal disease in children","volume":"25","author":"Groothoff","year":"2005","journal-title":"Perit Dial Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.308332","article-title":"Echocardiographic findings in children with chronic kidney disease","volume":"31","author":"Moustafa","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.01.011","article-title":"Adiposity, sex, and cardiovascular disease risk in children with CKD: A longitudinal study of youth enrolled in the chronic kidney disease in children (CKiD) study","volume":"76","author":"Brady","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2002.29865","article-title":"Leptin and renal disease","volume":"39","author":"Wolf","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B24","article-title":"Leptina (Leptin)","volume":"15","author":"Baptista","year":"2002","journal-title":"Acta Pediatr Port"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2017.11.006","article-title":"Soluble toll-like receptor 4: A new player in subclinical inflammation and malnutrition in hemodialysis patients","volume":"28","author":"Esposito","year":"2018","journal-title":"J Ren Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2022.05.003","article-title":"Sarcopenic obesity versus nonobese sarcopenia in hemodialysis patients: Differences in nutritional status, quality of life, and clinical outcomes","author":"Beberashvili","year":"2022","journal-title":"J Ren Nutr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S335694","article-title":"Higher serum leptin levels are associated with a reduced risk of sarcopenia but a higher risk of dynapenia among older adults","volume":"14","author":"Kao","year":"2021","journal-title":"J Inflamm Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2020.12.021","article-title":"Role of hormones in sarcopenia","volume":"115","author":"Priego","year":"2021","journal-title":"Vitam Horm"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032251","article-title":"Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity","volume":"89","author":"Misra","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020001","article-title":"Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence","volume":"87","author":"Kratzsch","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","article-title":"The renin-angiotensin system and the biology of skeletal muscle: mechanisms of muscle wasting in chronic disease states","volume":"127","author":"Delafontaine","year":"2016","journal-title":"Trans Am Clin Clim Assoc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22324","article-title":"Muscle-specific expression of IGF-1 blocks angiotensin II\u2013induced skeletal muscle wasting","volume":"115","author":"Song","year":"2005","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118698","article-title":"Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism","volume":"97","author":"Brink","year":"1996","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12905","article-title":"Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial","volume":"19","author":"Bergmark","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.06.011","article-title":"Adiponectin, cardiovascular disease, and mortality: parsing the dual prognostic implications of a complex adipekine","volume":"63","author":"Kizer","year":"2014","journal-title":"Metabolism"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1038\/s41598-019-52977-x","article-title":"Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial","volume":"9","author":"Kim-Mitsuyama","year":"2019","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0458","article-title":"Role of adipokines in cardiovascular disease","volume":"81","author":"Lau","year":"2017","journal-title":"Circ J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2011.226373","article-title":"Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure","volume":"97","author":"Van Berendoncks","year":"2011","journal-title":"Heart"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.885525","article-title":"Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure","volume":"3","author":"Van Berendoncks","year":"2010","journal-title":"Circ Hear Fail"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S100891","article-title":"Hypertension in pediatric patients with chronic kidney disease: management challenges","volume":"10","author":"Gallibois","year":"2017","journal-title":"J Nephrol Renov Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15630","article-title":"Cardiovascular disease in childhood and adolescence: Lessons from children with chronic kidney disease","volume":"110","author":"Quefeld","year":"2020","journal-title":"Acta Paediatr"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1120445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T05:59:33Z","timestamp":1678341573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1120445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":42,"alternative-id":["10.3389\/fendo.2023.1120445"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1120445","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"article-number":"1120445"}}